1. Home
  2. SDGR vs ARI Comparison

SDGR vs ARI Comparison

Compare SDGR & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • ARI
  • Stock Information
  • Founded
  • SDGR 1990
  • ARI 2009
  • Country
  • SDGR United States
  • ARI United States
  • Employees
  • SDGR N/A
  • ARI N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • ARI Real Estate Investment Trusts
  • Sector
  • SDGR Health Care
  • ARI Real Estate
  • Exchange
  • SDGR Nasdaq
  • ARI Nasdaq
  • Market Cap
  • SDGR 1.4B
  • ARI 1.5B
  • IPO Year
  • SDGR 2020
  • ARI 2009
  • Fundamental
  • Price
  • SDGR $20.87
  • ARI $10.06
  • Analyst Decision
  • SDGR Buy
  • ARI Buy
  • Analyst Count
  • SDGR 8
  • ARI 4
  • Target Price
  • SDGR $26.75
  • ARI $10.67
  • AVG Volume (30 Days)
  • SDGR 1.3M
  • ARI 835.8K
  • Earning Date
  • SDGR 11-05-2025
  • ARI 10-30-2025
  • Dividend Yield
  • SDGR N/A
  • ARI 9.90%
  • EPS Growth
  • SDGR N/A
  • ARI N/A
  • EPS
  • SDGR N/A
  • ARI N/A
  • Revenue
  • SDGR $237,917,000.00
  • ARI $273,783,000.00
  • Revenue This Year
  • SDGR $22.73
  • ARI $25.91
  • Revenue Next Year
  • SDGR $19.85
  • ARI $14.63
  • P/E Ratio
  • SDGR N/A
  • ARI N/A
  • Revenue Growth
  • SDGR 18.59
  • ARI 55.89
  • 52 Week Low
  • SDGR $16.60
  • ARI $7.70
  • 52 Week High
  • SDGR $28.47
  • ARI $11.11
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 50.88
  • ARI 46.12
  • Support Level
  • SDGR $19.99
  • ARI $10.15
  • Resistance Level
  • SDGR $23.02
  • ARI $10.35
  • Average True Range (ATR)
  • SDGR 1.12
  • ARI 0.18
  • MACD
  • SDGR 0.03
  • ARI 0.01
  • Stochastic Oscillator
  • SDGR 47.94
  • ARI 51.52

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: